Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

207
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
207
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

382
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
382
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

314
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
314
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

405
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
405
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

239
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications.

Microorganisms·2026
Same author

Bacillus-based biocontrol strategy for Pseudomonas aeruginosa-contaminated ICU sink drains: a proof-of-concept study.

The Journal of hospital infection·2026
Same author

Diagnostic and prognostic relevance of valve strands in patients with suspected infective endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Open-source large language model-based on-premises pipeline for automated data extraction from unstructured electronic health records: a pilot study.

BMJ health & care informatics·2026
Same author

Mind the Gap: Inadequate Performance of Embolic Risk Scores in Infective Endocarditis.

Open forum infectious diseases·2026
Same author

Evaluation of Plant-Guided Strategies Against Clinical Multidrug-Resistant Pathogens: Preliminary Phytochemical Screening, Antioxidant Capacity, and Antibacterial/Antibiofilm Activity of <i>Rosa canina</i> and <i>Colchicum autumnale</i> Extracts.

Antibiotics (Basel, Switzerland)·2026
Same journal

Defining Success and Failure In Prosthetic Joint Infections: A Meta-epidemiologic Study Toward A Core Outcome Set.

Open forum infectious diseases·2026
Same journal

A Call to Investigate the Association Between Histoplasmosis and Fatigue.

Open forum infectious diseases·2026
Same journal

Optimizing Hepatitis C Virus Antibody Testing Strategy and Setting: Results From a Large Real-World Screening Program.

Open forum infectious diseases·2026
Same journal

Influenza Vaccines for Persons Who Are Immunocompromised: A Scoping Review of the Literature.

Open forum infectious diseases·2026
Same journal

Mpox Disease Severity Reduced in Intradermally MVA-BN Vaccinated Compared to Unvaccinated Patients in Sweden: A Retrospective 2024-2025 Observational Case-series.

Open forum infectious diseases·2026
Same journal

Persistent Dominance of Serotype 3 in Noninvasive Pneumococcal Disease in Belgium (2022-2025).

Open forum infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.3K

Infective Endocarditis and Antimicrobial Timing: A Case for Delay?

Elisavet Stavropoulou1, Bruno Ledergerber2, Nicolas Fourré1

  • 1Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Open Forum Infectious Diseases
|October 27, 2025
PubMed
Summary
This summary is machine-generated.

For suspected infective endocarditis (IE), delaying antimicrobial treatment in stable patients until blood culture results are available does not worsen outcomes. This approach may offer a safer alternative to immediate empiric therapy.

Keywords:
Staphylococcus aureusantimicrobial treatmentbloodstream infectionempiric treatmentinfective endocarditis

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.8K
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

9.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.3K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.8K
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

9.1K

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Clinical Medicine

Background:

  • Current guidelines suggest prompt empiric antimicrobial treatment for suspected infective endocarditis (IE).
  • The clinical benefit of immediate treatment in hemodynamically stable patients with suspected IE is uncertain.
  • This study investigated the impact of deferring antimicrobial treatment in such patients.

Purpose of the Study:

  • To assess the clinical outcomes of deferring antimicrobial treatment in hemodynamically stable patients with suspected IE.
  • To compare 30-day mortality and a composite endpoint in patients receiving immediate versus deferred treatment.

Main Methods:

  • A multicenter cohort study included adult patients with bacteremia and suspected IE.
  • Patients with sepsis, ICU admission, neutropenia, or other infection sources were excluded.
  • Outcomes were adjudicated by an Endocarditis Team, comparing immediate (Group I) versus deferred (Group D) treatment.

Main Results:

  • No significant difference in 30-day mortality between immediate (5%) and deferred (5%) treatment groups.
  • For confirmed IE cases, the composite endpoint (mortality, embolic events, new bone/joint infection) showed no difference (28% vs 24%).
  • Empirical treatment was deferred in 45% of episodes.

Conclusions:

  • Deferring antimicrobial treatment in clinically stable patients with suspected IE is not associated with worse clinical outcomes.
  • This finding challenges the routine practice of immediate empiric treatment in all suspected IE cases.
  • Further research may refine treatment guidelines for hemodynamically stable patients.